Open-Label Placebo for Major Depressive Disorder: A Pilot Randomized Controlled Trial

被引：134
|
作者：
Kelley, John M. [1 ,2 ,3 ,4 ]
Kaptchuk, Ted J. [2 ,3 ]
Cusin, Cristina [3 ,4 ]
Lipkin, Samuel [3 ,4 ]
Fava, Maurizio [3 ,4 ]
机构：
[1] Endicott Coll, Dept Psychol, Beverly, MA 01915 USA
[2] Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Massachusetts Gen Hosp, Depress Clin & Res Program, Boston, MA USA
来源：
PSYCHOTHERAPY AND PSYCHOSOMATICS | 2012年 / 81卷 / 05期
关键词：
D O I：
10.1159/000337053
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：312 / 314
页数：3
相关论文
共 50 条
  • [11] Open-label placebo treatment in chronic low back pain: a randomized controlled trial
    Carvalho, Claudia
    Caetano, Joaquim Machado
    Cunha, Lidia
    Rebouta, Paula
    Kaptchuk, Ted J.
    Kirsch, Irving
    PAIN, 2016, 157 (12) : 2766 - 2772
  • [12] Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
    Nitzan, U.
    EUROPEAN PSYCHIATRY, 2023, 66 : S845 - S846
  • [13] Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
    Nitzan, U.
    EUROPEAN PSYCHIATRY, 2023, 66 : S845 - S846
  • [14] Open-Label Placebo Treatment for Experimental Pain: A Randomized-Controlled Trial with Placebo Acupuncture and Placebo Pills
    Lee, Seoyoung
    Choi, Dha-Hyun
    Hong, Minyoung
    Lee, In-Seon
    Chae, Younbyoung
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2022, 28 (02): : 136 - 145
  • [15] A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up
    Findling, Robert L.
    McCusker, Emily
    Strawn, Jeffrey R.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (06) : 355 - 365
  • [16] Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison
    Matreja, Prithpal S.
    Badyal, Dinesh K.
    Khosla, Prem
    Deswal, Randhir S.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2007, 22 (07) : 477 - 482
  • [17] Randomized, 8-week, double-blind, placebo-controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52-week open-label extension trial
    Inoue, Takeshi
    Nishimura, Akira
    Sasai, Kiyofumi
    Kitagawa, Tadayuki
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2018, 72 (02) : 103 - 115
  • [18] An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
    Santi, N. Simple
    Biswal, Sashi Bhusan
    Naik, Birendra Narayan
    Sahoo, Jyoti Prakash
    Rath, Bhabagrahi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [19] Randomized, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder
    DeMartinis, N.
    Yeung, P. P.
    Entsuah, R.
    Manley, A. L.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S233 - S234
  • [20] An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)
    Carina Joy Donegan
    Dimitri Daldegan-Bueno
    Rachael Sumner
    David Menkes
    William Evans
    Nicholas Hoeh
    Frederick Sundram
    Lisa Reynolds
    Rhys Ponton
    Alana Cavadino
    Todd Smith
    Partha Roop
    Nathan Allen
    Binu Abeysinghe
    Darren Svirskis
    Anna Forsyth
    Mahima Bansal
    Suresh Muthukumaraswamy
    Pilot and Feasibility Studies, 9
12345